Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2009 Feb 17;27(9):1419–1425. doi: 10.1200/JCO.2008.19.1684

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2009 by American Society of Clinical Oncology

PMC Copyright notice

Fig 1. — Patient demographic characteristics, prognostic factors (including stage, histology, and measurable disease), and stratification parameters (including maximal residual disease and intent to perform interval cytoreductive surgery). FIGO, International Federation of Gynecology and Obstetrics; CP, carboplatin and paclitaxel; CPG, carboplatin, paclitaxel, and gemcitabine; CPD, carboplatin, paclitaxel, and doxorubicin; CT→CP, carboplatin plus topotecan, then carboplatin plus paclitaxel; CG→CP, carboplatin plus gemcitabine, then carboplatin plus paclitaxel.